Schroders Capital invests more in Memo Therapeutics AG
LONDON: Schroders Capital Global Innovation Trust plc announced its follow-on investment in Memo Therapeutics AG, a late clinical-stage biotech company based in Switzerland. The Company invested CHF 0.5 million (£0.4 million) in Memo’s Series C extension financing round, which raised…